It alleviated joint inflammation and reduced paw edema. Infliximab improved the trabecular microstructure and reversed the tendinopathy induced by collagen-induced arthritis (CIA). The levels of TNF-α and IL-23 significantly decreased. The gene discussed is TNF; the disease is disease of the tendon.